GlassScriptPhysician profile
Steven Polasek
NPI 1548640857
$2,694.02
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.43 · 2021: $38.64 · 2022: $63.65 · 2023: $332 · 2024: $2,138 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,077 · Honoraria: $1,000 · Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,077.38 |
| Honoraria | $1,000.00 |
| Food and Beverage | $501.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Truabutment INC. | $2,077.38 | 2024 | |
| Ortho Organizers, INC. | $272.91 | 2023-2024 | Reveal Aligners, Carriere |
| Straumann USA LLC | $93.97 | 2025 | |
| Dentsply Sirona INC | $80.07 | 2021-2023 | Ossix Plus |
| Henry Schein, INC. | $64.06 | 2023 | |
| Kerr Corporation | $42.73 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $20.92 | 2022 | |
| Envista Holdings Corporation | $14.91 | 2025 | Maxcem Elite |
| Sonendo INC | $14.64 | 2023 | Gentlewave Console |
| Philips North America LLC | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Polasek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.